论文部分内容阅读
目的:评价阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:收集2010年6月—2012年7月间收治的小儿支原体肺炎患者病历166例,并将其随机分成两组,即对照组83例和治疗组83例;对照组采用红霉素治疗,治疗组采用阿奇霉素治疗。结果:治疗1周后,对照组总有效率为77.11%,治疗组总有效率为92.77%;治疗后患者发热及咳嗽平均天数,对照组分别为(6.3±1.9)d和(9.2±2.1)d,治疗组分别为(2.4±1.1)d和(4.2±1.4)d。结论:用阿奇霉素治疗小儿支原体肺炎的临床效果明显好于红霉素。
Objective: To evaluate the clinical efficacy of azithromycin in the treatment of mycoplasma pneumonia in children. Methods: A total of 166 cases of pediatric patients with mycoplasma pneumonia were collected from June 2010 to July 2012, and were randomly divided into two groups, 83 cases in the control group and 83 cases in the treatment group. The control group was treated with erythromycin, Treatment group with azithromycin treatment. Results: After 1 week of treatment, the total effective rate was 77.11% in the control group and 92.77% in the treatment group. The average days of fever and cough in the control group were (6.3 ± 1.9) d and (9.2 ± 2.1) days, respectively d, the treatment group were (2.4 ± 1.1) d and (4.2 ± 1.4) d. Conclusion: The clinical effect of azithromycin in treating children with mycoplasma pneumonia is obviously better than that of erythromycin.